New England Journal of Medicine Publishes Results of Study on Anti-Inhibitor Coagulant Prophylaxis in Hemophilia Patients with Inhibitors

November 4, 2011

The following is an excerpt from an article published in the New England Journal of Medicine. Read the full article here. Summary After exposure to factor VIII, alloantibodies (inhibitors) that neutralize factor VIII clotting function develop in approximately 30% of patients with severe hemophilia A.1 The development of high-titer factor VIII inhibitors (>5 Bethesda units […]